Internal Medicine, Hematology & Oncology · Suffolk, VA
NPI
1710237185
Since 2012
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
4
Medicare group memberships
Hospitals
5
Hospital affiliations
3910 Bridge Rd Ste 400
Suffolk, VA, 23435
Phone (757) 484-0215
Groups this clinician bills Medicare through
Medicare paid, 2024
$24K
259 services
Medicare patients, 2024
140
Average age 74
Drug cost, 2024
$3.6M
665 prescriptions
Company payments, 2025
$3,168
From 8 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hui Chen was code 99215 (office e&m - established), 145 times for 71 patients. In total Hui Chen billed 259 services in 6 codes, and Medicare paid $24K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 145 | 71 | $100.93 | $15K |
| 99214 Office E&M - Established | Office | 71 | 54 | $63.72 | $4,524 |
| 99205 Office E&M - New | Office | 29 | 29 | $120.26 | $3,487 |
| 99204 Office E&M - New | Office | 11 | 11 | $73.05 | $804 |
By year: 2022 $23K for 378 services; 2023 $20K for 229 services; 2024 $24K for 259 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hui Chen prescribed most often to Medicare patients was Lenalidomide, with 68 prescriptions and refills. In total Hui Chen wrote 665 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lenalidomide Generic | 68 | 68 | Under 11 | $1.0M |
| Letrozole Generic | 64 | 116 | 22 | $1,287 |
| Prochlorperazine Maleate Generic | 47 | 47 | 27 | $557 |
| Ondansetron Hcl Generic | 43 | 43 | 21 | $511 |
| Valacyclovir Valacyclovir Hcl | 36 | 46 | Under 11 | $938 |
| Imatinib Mesylate Generic | 35 | 35 | Under 11 | $37K |
| Xtandi Enzalutamide | 32 | 32 | Under 11 | $437K |
| Tamoxifen Citrate Generic | 23 | 29 | Under 11 | $404 |
| Exemestane Generic | 22 | 32 | Under 11 | $1,161 |
| Loperamide Loperamide Hcl | 20 | 20 | Under 11 | $213 |
| Eliquis Apixaban | 19 | 19 | Under 11 | $11K |
| Potassium Chloride Generic | 19 | 21 | Under 11 | $300 |
| Dexamethasone Generic | 18 | 22 | 12 | $299 |
| Jakafi Ruxolitinib Phosphate | 16 | 16 | Under 11 | $280K |
| Pomalyst Pomalidomide | 14 | 14 | Under 11 | $317K |
Brand drugs: 172 claims; generic drugs: 493 claims; opioid claims: 28.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hui Chen $3,168 ($3,168 in general payments such as food, travel and fees) from 8 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $3,015.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.